| Literature DB >> 33456247 |
V P Anshida1, R Anitha Kumari1, Chethana S Murthy1, Anoop Samuel2.
Abstract
Matrix metalloproteinases (MMPs) are a group of over 25 secreted and membrane-bound enzymes responsible for pericellular substrate degeneration. In response to injury, they play key roles in morphogenesis, wound healing, tissue repair and remodeling. They have been isolated from dentin, odontoblasts, pulp and periapical tissue. They play a major role in the formation of dentin matrix and secondary and tertiary dentin. These are also responsible for releasing dentinal growth factors. MMP family proteins elicit a dual role in the pathogenesis of inflammation, stimulating protective innate and/or adaptive immune functions, as well as tissue destruction. The main organic component of tooth structure is collagen, and MMPs that degrade collagen and the extracellular matrix have been implicated in the progression of dental caries, dental erosion as well as degradation of the hybrid layer. MMPs have also been shown to be active in pulpitis, and studies have shown that they can be used as diagnostic markers of pulpal and periapical inflammation. This review describes the role of MMPs in dental caries, dental erosion, bond stability as well as in pulpal and periapical inflammation. Copyright:Entities:
Keywords: Extracellular matrix; matrix metalloproteins; tissue inhibitors of metalloproteinases
Year: 2020 PMID: 33456247 PMCID: PMC7802866 DOI: 10.4103/jomfp.JOMFP_34_20
Source DB: PubMed Journal: J Oral Maxillofac Pathol ISSN: 0973-029X
Figure 1Schematic representation of the domain structures of matrix metalloproteinase (Cem Kuscu et al., 2020)
Figure 2(a) A conserved cysteine residue (C) in the pro-domain coordinates with the Zn2+ ion at the functional site of the catalytic domain. (b) The pro-domain is removed by cleavage in the pro-domain and between the pro-domain and the catalytic domain (modified from Page-McCaw et al., 2007)
Figure 3Matrix metalloproteinases, extracellular matrix substrates and analysis (Maciejczyk et al.)
Matrix metalloproteinases - source, conducted studies (developed by author)
| Source | MMP’s/cathepsin | Conducted studies |
|---|---|---|
| Saliva | MMP-9, MMP-8 Cathepsin B | (Tjäderhane |
| MMPS in pulp, odontoblasts and predentin | MMP-2, MMP-3, MMP-8, MMP-9, MMP-13 and MMP-20 | (Sulkala |
| Dentinal fluid | Cathepsin K and cathepsin B, MMP-2, MMP-9 | (Vidal |
MMPS: Matrix metalloproteinases
Classification of matrix metalloproteinases inhibitors (developed by author)
| Endogenous/natural | Exogenous/synthetic | Exogenous natural |
|---|---|---|
| TIMP-1, -2, -3, -4 | Bisphosphonates | PA Grape seed extract, coco seed exract-PA |
| Bisbiguanides-CHX | ||
| Tetracycline-minocycline, doxycycline | Flavanoids | |
| CMT-1, -3, -8 | Bilberry, cranberry, apple, black tea and green tea contain these flavonoids | |
| Hydroxamates-Marimastat, Batimastat | flavonoids from Passiflora foetida | |
| (BB94), Glaradin (GM6001), CT116 | Green teat extract-EGCG | |
| Quarternary ammonium compounds | Morus nigra (black mulberry) and Morus alba (white mulberry) | |
| Chelating agents like EDTA | Mulberry leaf extract | |
| FeSO4, ZnCl2, ZnO | Barbadensis Miller (Aloe vera) | |
| Oleic acid | Curcumin from Curcuma longa | |
| Carbodimide | Avacado | |
| Soyabean | ||
| Chitosan |
PA: Proanthocyanides, EGCG: Epigallocatechin-gallate, EDTA: Ethylene diamine tetraacetic acid, CHX: Chlorhexidine, CMT: Chemically modified tetracyclines